KRAS and cancer: Accordingly, our study aimed to investigate the functional behavior of these KRAS and PIK3CA cancer-driver genes along with identifying the somatic mutations associated with the aggressive benign tumor in the developed immortalized endometriotic epithelial cell line, HMOsisEC10.